Table 2:
miRNAs that change over time in the entire cohort
miRNAs Decreased with Treatment | miRNAs Increased with Treatment | ||||
---|---|---|---|---|---|
miRNA | Spearman rho | P-value | miRNA | Spearman rho | P-value |
34a-5p | −0.62 | 4.6 × 10−7 | 374a-5p | 0.31 | 3.4 × 10−2 |
885-5p | −0.53 | 1.8 × 10−5 | 423-5p | 0.31 | 3.2 × 10−2 |
122-5p | −0.47 | 3.4 × 10−4 | 106b-5p | 0.32 | 2.7 × 10−2 |
215-5p | −0.45 | 5.6 × 10−4 | 363-3p | 0.32 | 2.9 × 10−2 |
148a-3p | −0.44 | 9.7 × 10−4 | 140-5p | 0.35 | 1.2 × 10−2 |
100-5p | −0.42 | 1.5 × 10−3 | 18a-5p | 0.36 | 8.2 × 10−3 |
125b-5p | −0.4 | 2.9 × 10−3 | 93-5p | 0.39 | 3.8 × 10−3 |
192-5p | −0.4 | 3.5 × 10−3 | 106a-5p | 0.4 | 2.7 × 10−3 |
30a-5p | −0.4 | 2.7 × 10−3 | |||
194-5p | −0.38 | 5.6 × 10−3 |
Shown are miRNAs with significantly different expression at week 240 relative to week 0 considering all 28 patients.